p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
about
Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturitionPost-translational modifications of the progesterone receptorsDistribution of estrogen and progesterone receptors isoforms in endometrial cancer.A new strategy for selective targeting of progesterone receptor with passive antagonists.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsDifferential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancerIn vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cellsProgesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexesThe requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specificProliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.Inflammatory Stimuli Increase Progesterone Receptor-A Stability and Transrepressive Activity in Myometrial Cells.Progesterone Receptor Signaling in Uterine Myometrial Physiology and Preterm Birth.Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation.Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.
P2860
Q26745938-F77B1F56-6A92-4609-90D3-F469DC6E1A43Q27010251-4F2307F6-2E8B-4CB6-8B6D-C0951ABC3C80Q33616773-9FEB7CD0-C4B6-4992-9E98-F56D5F8748CAQ33633141-3E19C137-AFAA-4098-AED7-9611415EED6CQ34317537-7865B4CE-3D33-46D2-9329-655D3415E063Q34430545-EA089B60-0357-47AD-B385-8FF0907CA4C3Q34654640-2A8E9C58-EE9A-4389-882E-C02EF446A5E5Q36274172-13A1F631-929C-4F97-B199-A3DE96EF3062Q36803178-F335F789-7D74-4CE7-AC9D-4AD7BBA31328Q36807752-39FF6F05-A4FA-4FAD-A557-BE14C64FD5B7Q37564411-47B292BA-DE42-4F57-84DD-4E6C055B352CQ38729004-5F600F4C-708C-466B-AD44-CCBCF2875E3CQ39319711-35117B70-1A02-4118-8EA1-EBCA8D8C9906Q47307932-0627FFC0-8781-41FB-A613-B469AC930152Q52751765-0DCCB5BD-1F5F-4D63-961B-01A0EC45199D
P2860
p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@ast
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@en
type
label
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@ast
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@en
prefLabel
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@ast
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@en
P2093
P2860
P356
P1476
p38 and p42/44 MAPKs different ...... A and B isoform stabilization.
@en
P2093
Anne Guiochon-Mantel
Catherine Bellance
Hugues Loosfelt
Junaid A Khan
Larbi Amazit
Marc Lombès
P2860
P304
P356
10.1210/ME.2011-1042
P577
2011-08-04T00:00:00Z